Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 12
Submit an article Journal homepage
54
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis

Deeya Gaindh Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
,
Neal Jeffries Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland 20892, USA
,
Joan Ohayon Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
,
Nancy D Richert Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
,
Clelia Pellicano Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
,
Joseph A Frank Laboratory of Diagnostic Radiology and Research, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland 20892, USA
,
Henry McFarland Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
&
Francesca Bagnato Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 10 Center Drive, Bethesda, Maryland 20892, USA +1 301 594 1415; +1 301 402 0373; [email protected]
 show all
Pages 1823-1829 | Published online: 06 Nov 2008

Bibliography

  • McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-66
  • Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116:1077-94
  • Bastianello S, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990;40:591-5
  • Hawkins CP, Munro PM, MacKenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113:365-78
  • Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990;113:1477-89
  • Harris JO, Frank JA, Patronas N, et al. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-55
  • Stone LA, Frank JA, Albert PS, et al. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995;37:611-9
  • Clerico M, Contessa G, Dorelli L. Interferon-ß1a for the treatment of multiple sclerosis. Expert Opin Biol Ther 2007;7:535-42
  • Bermel RA, Rudick RA. Interferon-beta treatment for multiple sclerosis. Neurotherapeutics 2007;4:633-46
  • Markowitz CE. Interferon-β: mechanism of action and dosing issues. Neurology 2007;12,68(24 suppl 4):S8-11
  • Pozzilli C, Bastianello S, Koudriavtseva T, et al. Magnetic resonance imaging changes with recombinant human interferon-β-1a: a short-term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;61:251-8
  • Miller DH, Molyneux PD, Barker GJ, et al. Effect of interferon-β1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. Ann Neurol 1999;46:850-9
  • Filippi M, Rovaris M, Capra R, et al. Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology. J Neurol Neurosurg Psychiatry 1999;67:386-9
  • Brex PA, Molyneux PD, Smiddy P, et al. The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS. Neurology 2001;57:2185-90
  • Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992;159:1041-7
  • Secondary progressive efficacy clinical trial of recombinant interferon-beta-1a in MS (SPECTRIMS STUDY GROUP). Randomized controlled trial of interferon-beta-1a in secondary progressive MS: clinical results. Neurology 2001;56:1496-504
  • Paolillo A, Bastianello S, Frontoni M, et al. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 1999;6:455-9
  • Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-93
  • Hiehle JF, Grossman RI, Ramer KN, et al. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77
  • Filippi M, Rocca MA, Comi G. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement. J Neurol Sci 1998;159:162-5
  • Gupta S, Solomon JM, Tasciyan TA, et al. Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Mult Scler 2005;11:658-68
  • Di Rezze S, Gupta S, Durastanti V, et al. An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis. Mult Scler 2007;13:343-7
  • Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52
  • Panitch H, Goodin DS, Francis G, et al. Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial. Neurology 2002;59:1496-506
  • Leary SM, Miller DH, Stevenson VL, et al. Interferon β-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology 2003;60:44-51
  • Medical Numerics, Inc. MEDx 3.42. Available from: www.medicalnumerics.com. [last accessed 3 October 2008]
  • Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-56
  • van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19: 675-83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.